Home>drugs by ailments>Anemia due to chronic kidney disease>pegylated recombinant human erythropoietin
Pegylated Recombinant Human Erythropoietin
Information about Pegylated Recombinant Human Erythropoietin
Pegylated Recombinant Human Erythropoietin Uses
Pegylated Recombinant Human Erythropoietin is used in the treatment of anemia due to chronic kidney disease and anemia due to chemotherapy.
How Pegylated Recombinant Human Erythropoietin works
Pegylated Recombinant Human Erythropoietin contains a man-made form of Erythropoietin, a hormone that is produced mainly by specialized cells in the kidney. It acts on red blood cells to protect them against destruction. At the same time, it stimulates stem cells of the bone marrow to increase the production of red blood cells and provides homeostasis in oxygen delivery to body tissue.
Available Medicine for Pegylated Recombinant Human Erythropoietin
ErypegIntas Pharmaceuticals Ltd
₹3350 to ₹98314 variant(s)
Expert advice for Pegylated Recombinant Human Erythropoietin
- Pegylated Recombinant Human Erythropoietin helps in the treatment of anemia that may have occurred due to chronic kidney disease or cancer chemotherapy.
- It is given as a single injection under your skin.
- Your doctor may get your blood tests done regularly to monitor the levels of hemoglobin, blood cells and electrolytes such as potassium in your blood.
- Monitor your blood pressure regularly while taking this medication. Inform your doctor if you notice symptoms of very high blood pressure such as severe headache, problems with your eyesight, nausea, vomiting or fits (seizures).
- Stop taking Pegylated Recombinant Human Erythropoietin and inform your doctor if you develop shortness of breath or skin rash.